Literature DB >> 2758359

Inflammatory and immunological cell profiles in a rat model of conjunctival immediate hypersensitivity.

M J Doherty1, D L Easty.   

Abstract

A modified model of conjunctival immediate hypersensitivity in the rat is described. The advantages of this model over previously reported rat models are that it does not require invasive challenges, pre-treatment with mucolytic agents to enhance antigen penetration, or the use of haptens, and is therefore more representative of the mode of allergen challenge seen in human hay fever conjunctivitis. This model has been shown to have both early and late-phase cellular responses but only early phase clinical signs. During the early phase of the response the tarsal region accommodates a massive neutrophil infiltration and the fornix-bulbar region participates to a greater extent during the late-phase reaction, with a significant eosinophil infiltration. The development of this model has allowed us to gain a clearer insight into the mechanisms involved during conjunctival immediate hypersensitivity in the rat; and the simplicity of this model makes it attractive to use in the evaluation of new drug therapies prior to their introduction into human clinical trials.

Entities:  

Mesh:

Year:  1989        PMID: 2758359     DOI: 10.1111/j.1365-2222.1989.tb02413.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  3 in total

1.  Exertion of the suppressive effects of IFN-gamma on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase.

Authors:  A Fukushima; K Fukata; A Ozaki; M Takata; N Kuroda; H Enzan; H Ueno
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

2.  Activated T cells in an animal model of allergic conjunctivitis.

Authors:  I Carreras; B Carreras; L McGrath; A Rice; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

3.  Allergic conjunctivitis and uveitis models: reappraisal with some marketed drugs.

Authors:  E Khosravi; P P Elena; C Hariton
Journal:  Inflamm Res       Date:  1995-01       Impact factor: 4.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.